Nicholas A. Smith

Array ( [id] => 7591160 [patent_doc_number] => 07662925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 11/483250 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 59 [patent_no_of_words] => 87160 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662925.pdf [firstpage_image] =>[orig_patent_app_number] => 11483250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219286 [patent_doc_number] => 20070160597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 11/483378 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 87858 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160597.pdf [firstpage_image] =>[orig_patent_app_number] => 11483378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724432 [patent_doc_number] => 08097703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'CD19 antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 11/917750 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 39533 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097703.pdf [firstpage_image] =>[orig_patent_app_number] => 11917750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754838 [patent_doc_number] => 20060223987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Novel beta-defensins' [patent_app_type] => utility [patent_app_number] => 11/450178 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22281 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223987.pdf [firstpage_image] =>[orig_patent_app_number] => 11450178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732281 [patent_doc_number] => 20060257398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Anti-CD19 antibodies' [patent_app_type] => utility [patent_app_number] => 11/445410 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22526 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257398.pdf [firstpage_image] =>[orig_patent_app_number] => 11445410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999273 [patent_doc_number] => 20070041907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Immunoglobulin molecules with improved characteristics' [patent_app_type] => utility [patent_app_number] => 11/445475 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11688 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041907.pdf [firstpage_image] =>[orig_patent_app_number] => 11445475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514268 [patent_doc_number] => 20090214574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Anti-cd16 binding molecules' [patent_app_type] => utility [patent_app_number] => 11/921123 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19224 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214574.pdf [firstpage_image] =>[orig_patent_app_number] => 11921123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921365 [patent_doc_number] => 20060240008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor' [patent_app_type] => utility [patent_app_number] => 11/439906 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15717 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240008.pdf [firstpage_image] =>[orig_patent_app_number] => 11439906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760124 [patent_doc_number] => 20060211069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor' [patent_app_type] => utility [patent_app_number] => 11/437009 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9267 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211069.pdf [firstpage_image] =>[orig_patent_app_number] => 11437009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760122 [patent_doc_number] => 20060211067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor' [patent_app_type] => utility [patent_app_number] => 11/436652 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9269 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211067.pdf [firstpage_image] =>[orig_patent_app_number] => 11436652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5254164 [patent_doc_number] => 20070135620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Fc variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 11/436266 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 29125 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135620.pdf [firstpage_image] =>[orig_patent_app_number] => 11436266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5022198 [patent_doc_number] => 20070148164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/432872 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 102899 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148164.pdf [firstpage_image] =>[orig_patent_app_number] => 11432872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887593 [patent_doc_number] => 20060275283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Fcgamma receptor-binding polypeptide variants and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/433313 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42498 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275283.pdf [firstpage_image] =>[orig_patent_app_number] => 11433313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971279 [patent_doc_number] => 20070111281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Antigen binding molecules having modified Fc regions and altered binding to Fc receptors' [patent_app_type] => utility [patent_app_number] => 11/430283 [patent_app_country] => US [patent_app_date] => 2006-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 40114 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111281.pdf [firstpage_image] =>[orig_patent_app_number] => 11430283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903666 [patent_doc_number] => 07335742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 11/429786 [patent_app_country] => US [patent_app_date] => 2006-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 40244 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335742.pdf [firstpage_image] =>[orig_patent_app_number] => 11429786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860673 [patent_doc_number] => 07371826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 11/429793 [patent_app_country] => US [patent_app_date] => 2006-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 40260 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371826.pdf [firstpage_image] =>[orig_patent_app_number] => 11429793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705242 [patent_doc_number] => 20060194290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 11/429792 [patent_app_country] => US [patent_app_date] => 2006-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40266 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194290.pdf [firstpage_image] =>[orig_patent_app_number] => 11429792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867476 [patent_doc_number] => 07364731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Polypeptide variants' [patent_app_type] => utility [patent_app_number] => 11/429362 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 24300 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364731.pdf [firstpage_image] =>[orig_patent_app_number] => 11429362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624852 [patent_doc_number] => 20060263357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Anti-CD19 antibody therapy for autoimmune disease' [patent_app_type] => utility [patent_app_number] => 11/429545 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 61640 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263357.pdf [firstpage_image] =>[orig_patent_app_number] => 11429545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629553 [patent_doc_number] => 08008443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Modulation of antibody effector function by hinge domain engineering' [patent_app_type] => utility [patent_app_number] => 11/912562 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 59472 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008443.pdf [firstpage_image] =>[orig_patent_app_number] => 11912562 [rel_patent_id] =>[rel_patent_doc_number] =>)